Month: September 2020

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) refers to its announcement dated 10 September 2020 regarding the redelivery of Ivan Gubkin (the “I.G.”, previously “Polarcus Amani”).Sovcomflot completed the redelivery process for the I.G. on 25 September 2020. The vessel has been renamed Polarcus Amani and will remain stacked in Lyngdal, Norway until market conditions support reactivation.Sovcomflot continues to evaluate seismic acquisition opportunities for the vessel in 2021. Polarcus is assessing opportunities for Polarcus Amani as a source vessel and/or streamer vessel in the international market. ContactsHans-Peter Burlid, CFO+971 50 559 8175hp.burlid@polarcus.com About PolarcusThis information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

BIRMINGHAM, Ala., Sept. 25, 2020 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc. (NASDAQ: SFBS) is scheduled to announce earnings and operating results for the quarter ended September 30, 2020 on October 19, 2020 at 4 p.m. ET. The news release will be available at www.servisfirstbancshares.com.ServisFirst Bancshares, Inc. will host a live audio webcast to discuss earnings and results on Monday, October 19, 2020 beginning at 5:15 p.m. ET. The audio webcast can be accessed at www.servisfirstbancshares.com. A replay of the call will be available until October 30, 2020.About ServisFirst Bancshares, Inc.ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Birmingham,...

Chr. Hansen Holding A/S has today entered into an agreement to divest its Natural Colors business to the EQT IX Fund for a cash consideration of 800 EUR million on cash and debt free basis. The transaction is expected to close during the spring of 2021, subject to regulatory approvals.This agreement concludes the strategic review of the Company’s portfolio announced in July 2020, where Chr. Hansen’s Board of Directors and the Executive Board decided to explore strategic options for the Natural Colors business as it does not share the microbial and fermentation technology platforms.Mauricio Graber, CEO of Chr. Hansen, said: “The divestment of Natural Colors completes the Review part of our recently launched 2025 Strategy. Chr. Hansen can now focus on fulfilling the ambition of becoming a pure-play, microbial and fermentation company with...

This news release is not for distribution to United States services or for dissemination in the United StatesVANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the “Company” or “Macarthur”) is seeking an extension period of time under BC 51-517, section 4.2(l)(j) for the filing of a technical report National Instrument 43-101 Standards of Disclosure for Mineral Projects, pertaining to its Lake Giles Iron Project.The Company expects to file the report on or before 10 November 2020 and confirms that Management and other insiders are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207.Since the filing of the Company last interim financial report on 1 September 2020, the following material business developments...

LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced CEO Fred Chereau will present at the Jefferies Virtual Gene Editing/Therapy Summit on Friday, October 2, 2020 at 11:30 AM, ET.A live audio webcast of the presentation will be available under the “Events and Presentations” section of LogicBio’s website. A replay of the presentation will become available approximately one hour after the event and will be archived for 30 days.About LogicBio TherapeuticsLogicBio Therapeutics is a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients with significant unmet medical needs using GeneRide™, its proprietary technology...

LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced CEO Fred Chereau will present at the Chardan Virtual Genetic Medicines Conference on Monday, October 5, 2020 at 11 AM, ET.A live audio webcast of the presentation will be available under the “Events and Presentations” section of LogicBio’s website. A replay of the presentation will become available approximately one hour after the event and will be archived for 30 days.About LogicBio TherapeuticsLogicBio Therapeutics is a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients with significant unmet medical needs using GeneRide™, its proprietary technology platform....

VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Further to its announcement regarding leadership change in respect of the Chief Financial Officer role (see news release dated August 31, 2020), Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) announces that Tom S.Q. Yip, Executive Vice President and Chief Financial Officer, will step down from his role as Chief Financial Officer of the Company on September 30, 2020. Mr. Yip will continue to serve as Executive Vice President and assist with an orderly transition until October 30, 2020. Matthew Quinlan, Vice President, Finance, will succeed Mr. Yip as Chief Financial Officer of the Company effective September 30, 2020.Additionally, Pretivm announces that Kenneth C. McNaughton, Vice President and Chief Exploration Officer, has informed the Company that...

VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — Juggernaut Exploration Ltd. (TSX-V: JUGR) (OTCQB: JUGRF) (FSE: 4JE) (the “Company” or “Juggernaut”) is pleased to announce amended terms for the 100% controlled Empire property. All future cash payments totalling $3,500,000 have been removed entirely and as per the existing agreement, the issuance of 4,100,000 shares by March 30, 2021, have been reduced significantly to 1,700,000 shares and warrants. $11,500,000 in exploration costs to be incurred by December 31, 2023, has been reduced to $500,000 in aggregate on the Empire and/or Midas properties by December 15, 2022. As per the existing agreement, the issuance of 4,100,000 shares upon the completion of feasibility on the Empire property by March 30, 2025 has now been extended to December 15, 2027 (optional). The warrants...

Complete Response Letter cites exposure levels (Cmax) in certain weight groupsNo additional clinical studies anticipated by AquestiveNo Clinical Safety issues or Non-Clinical Chemistry, Manufacturing and Controls (CMC) issues identifiedConference call and webcast today at 6:30 p.m. ETWARREN, N.J., Sept. 25, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for Libervant™ (diazepam) Buccal Film for management of seizure clusters. The FDA issues a CRL to indicate that the review cycle for an application is complete...

NEWARK, Del., Sept. 25, 2020 (GLOBE NEWSWIRE) — Artesian Resources Corporation (NASDAQ: ARTNA) announced today that its Board of Directors has approved a 3% increase in the company’s Class A and Class B Common Stock dividend, raising the annual dividend to $1.0284 per share. The quarterly dividend of $0.2571 is payable November 20, 2020 to shareholders of record at the close of business on November 9, 2020.“We are pleased to announce this 3% dividend increase. Our Artesian team continues to work diligently to expand our water and wastewater businesses significantly, while generating strong financial results. We look forward to continuing our successful acquisitions, growing our customer base and increasing our revenues to provide consistent returns to our shareholders,” said Dian C. Taylor, Chair, President and CEO.Artesian Resources...